We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 787

By the Book: Hip Implant Claims Dismissed in Middle District of Florida
  • Reed Smith LLP
  • USA
  • September 21 2018

Recently, the Enviably Youthful Drug and Device Law Mother has been pushing us to plan a motherdaughter vacation. Her longtime companion no longer


Taking Out the Laundry With TwIqbal
  • Reed Smith LLP
  • USA
  • August 22 2018

In medical device product liability cases to which preemption by reason of FDA pre-market approval (“PMA”) applies, courts have consistently


FDA: “Milk” Probably Was a Bad Choice
  • Reed Smith LLP
  • USA
  • July 26 2018

Apparently even the Food and Drug Administration (FDA) is on board with ‘90s nostalgia. This week, the agency effectively rebooted the nearly


House Approves Sweeping Opioid PreventionTreatment Legislation
  • Reed Smith LLP
  • USA
  • July 5 2018

The House of Representatives has overwhelmingly approved bipartisan legislation, HR 6, the SUPPORT for Patients and Communities Act, intended to


Sixth Circuit Finds Failure to Distribute Medication Guide Claim Preempted
  • Reed Smith LLP
  • USA
  • July 3 2018

Being that it was the Sixth Circuit that allowed a failure-to-update claim to proceed against a generic manufacturer, when we got the recent decision


Breaking News - Supreme Court Grants Review in Fosamax Preemption Case
  • Reed Smith LLP
  • USA
  • June 28 2018

Today, on the last day of the United States Supreme Court’s 2018 Term, the Court issued an order granting review (“certiorari”) in Merck Sharp & Dohme


Seventh Circuit Upholds FDA’s Use of FOIA Exemptions to Refuse Disclosures to Plaintiff
  • Reed Smith LLP
  • USA
  • June 20 2018

On this date 46 years ago, President Nixon and his aides had a conversation about the Watergate break-in and cover-up. What did they say? We do not


Potentially, the Mother of All Off-Label Uses, as FDA Backs Down
  • Reed Smith LLP
  • USA
  • June 14 2018

Researchers at Temple University here in Philly recently published a scientific article, “Learning Impairments, Memory Deficits, and Neuropathology in


Still No Causation, Still No “Parallel Claim”
  • Reed Smith LLP
  • USA
  • May 31 2018

We have made it no secret that we think the Ninth Circuit wrongly decided Stengel v. Medtronic. That is the case where the Ninth Circuit reversed


Breaking News - Solicitor General Recommends Grant and Reversal in Fosamax Appeal
  • Reed Smith LLP
  • USA
  • May 23 2018

We immediately called for the further appeal and reversal of the hideous decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation